FDA Inspection 1002862 — Community Blood Center
The FDA completed an inspection of Community Blood Center on Mar 8, 2017 in Bensalem, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 8, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Bensalem, PA (United States)